|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 18,999.05 INR | -2.65% |
|
+0.44% | +25.07% |
| Market Cap | 244B 2.55B 2.24B 2.08B 1.91B 3.61B 3.69B 24.75B 9.69B 120B 9.57B 9.36B 414B | P/E 2027 * |
58.1x | P/E 2028 * | 42.1x |
|---|---|---|---|---|---|
| Enterprise Value | 247B 2.58B 2.27B 2.1B 1.93B 3.65B 3.73B 25.05B 9.81B 121B 9.69B 9.47B 419B | EV / Sales 2027 * |
10.7x | EV / Sales 2028 * | 8.84x |
| Free-Float |
62.24% | Yield 2027 * |
0.07% | Yield 2028 * | 0.1% |
Last Transcript: Neuland Laboratories Limited
| 1 day | -2.65% | ||
| 1 week | +0.44% | ||
| Current month | +1.98% | ||
| 1 month | +10.60% | ||
| 3 months | +27.09% | ||
| 6 months | +29.17% | ||
| Current year | +25.07% |
| 1 week | 18,622.95 |  | 20,072 |
| 1 month | 16,569.95 | | 20,072 |
| Current year | 11,500 | | 20,072 |
| 1 year | 11,500 | | 20,072 |
| 3 years | 2,911.7 | | 20,072 |
| 5 years | 965.85 | | 20,072 |
| 10 years | 247.3 | | 20,072 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 46 | 2026-03-31 | |
Abhijit Majumdar
DFI | Director of Finance/CFO | - | 2022-11-22 |
Ajitabh Singh
CTO | Chief Tech/Sci/R&D Officer | - | 2023-02-28 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 50 | 2001-12-31 | |
| Chairman | 82 | 1984-01-06 | |
| Director/Board Member | 46 | 2007-02-28 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.65% | +0.44% | +54.39% | +540.97% | 2.63B | |
| -0.56% | -2.64% | +49.04% | +168.24% | 1,060B | |
| +0.31% | -2.00% | +64.29% | +63.06% | 619B | |
| -0.03% | -5.01% | +28.86% | +83.73% | 438B | |
| -1.75% | -2.91% | +28.78% | +24.35% | 333B | |
| +0.24% | -2.61% | +29.46% | +46.50% | 282B | |
| -1.75% | -12.77% | +20.67% | +23.05% | 267B | |
| +0.67% | -0.76% | -26.10% | -37.25% | 218B | |
| -0.81% | -3.66% | +22.07% | +59.72% | 196B | |
| +1.21% | +0.10% | +19.85% | +72.03% | 161B | |
| Average | -0.66% | -2.68% | +29.13% | +104.44% | 357.65B | |
| Weighted average by Cap. | -0.13% | -3.09% | +36.28% | +83.32% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 23.09B 241M 212M 197M 181M 342M 349M 2.34B 918M 11.35B 907M 887M 39.23B | 27.8B 291M 255M 237M 218M 411M 420M 2.82B 1.11B 13.67B 1.09B 1.07B 47.24B |
| Net income | 4.21B 44.02M 38.66M 35.87M 32.97M 62.31M 63.65M 427M 167M 2.07B 165M 162M 7.15B | 5.81B 60.72M 53.32M 49.47M 45.47M 85.94M 87.79M 590M 231M 2.85B 228M 223M 9.87B |
| Net Debt | 2.94B 30.72M 26.98M 25.03M 23.01M 43.48M 44.42M 298M 117M 1.44B 115M 113M 4.99B | 1.92B 20.08M 17.64M 16.36M 15.04M 28.42M 29.04M 195M 76.36M 944M 75.41M 73.75M 3.26B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-13 | ₹18,999.05 | -2.65% | 1,908 |
| 26-07-10 | ₹19,516.65 | -0.01% | 1,586 |
| 26-07-09 | ₹19,519.45 | +3.53% | 3,876 |
| 26-07-08 | ₹18,854.00 | -0.29% | 2,572 |
| 26-07-07 | ₹18,908.70 | +0.26% | 1,093 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- NEULANDLAB Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
